• Sign In
  • My Marketwire Account
  • Marketwire Resonate
  • News Dashboard 2.0
  • Mediahub
  • Personal Beat
  • Hot Off the Wire
• Register
• Français
• Marketwired Blog
• Careers
• Contact Marketwired

Browse By:

• Industry
  • Aerospace and Defense
  • Agriculture
  • Automotive
  • Chemicals
  • Computers and Software
  • Education and Training
  • Electronics and Semiconductors
  • Energy and Utilities
  • Environment
  • Financial Services
  • Food and Beverage
  • Government
  • Lifestyle and Leisure
  • Manufacturing and Production
  • Media and Entertainment
  • Medical and Healthcare
  • Pharmaceuticals and Biotech
  • Professional Services
  • Real Estate and Construction
  • Retail
  • Sports
  • Telecom
  • Transportation and Logistics
  • Travel and Hospitality
• Topic
  • Associations
  • Bankruptcy
  • Class action
  • Conference calls
  • Dividends
  • Earnings
  • Earnings projections
  • Financing agreements
  • Initial public offerings
  • Investment opinion
  • Management changes
  • Media advisory
  • Mergers and acquisitions
  • Special news events
  • Stock splits
  • Stock/other market news
  • Trade shows
  • Webcasts
• Type
  • News Releases
  • Media Advisories
  • Feature Packs
  • Webcasts
  • Social Media 2.0

News Room: Biotech

Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology
MADISON, WI--(Marketwired - May 24, 2013) -  Quincy Bioscience, a leading research company committed to the discovery and development of calcium-binding proteins to...(more)
Quincy Bioscience  
May 24, 2013 09:13 ET
 

 

Med BioGene Announces Warrant Exercises
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 24, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that 2,318,000 warrants and agents' warrants to purchase an equal number...(more)
Med BioGene Inc.  
May 24, 2013 08:30 ET
 

 

Adherex Reports Feedback from the FDA from End of Phase 2 Meeting
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 23, 2013) - Adherex Technologies Inc. (TSX:AHX)(OTCQB:ADHXF), today announced that it has received feedback from the FDA at...(more)
Adherex Technologies Inc.  
May 23, 2013 21:07 ET
 

 

Theravance to Present at Investor Conferences in June 2013
SOUTH SAN FRANCISCO, CA--(Marketwired - May 23, 2013) -  Theravance, Inc. (NASDAQ: THRX) announced today that Rick E Winningham, Theravance's Chief Executive Officer, is scheduled to present at...(more)
Theravance, Inc.  
May 23, 2013 16:05 ET
 

 

La Jolla Pharmaceutical Company Releases Data Indicating GCS-100 May Improve Renal Function
SAN DIEGO, CA--(Marketwired - May 23, 2013) - La Jolla Pharmaceutical Company (OTCBB: LJPC) ("La Jolla" and "Company"), a leader in the development of therapeutics targeting galectin proteins...(more)
La Jolla Pharmaceutical Company  
May 23, 2013 15:37 ET
 

 

Type 2 Diabetes in Youth Progresses Faster, More Aggressively Than in Adults, Even Under Optimal Treatment Conditions
ALEXANDRIA, VA--(Marketwired - May 23, 2013) - Even when they receive the best currently available treatment and close monitoring of their condition, American youth with type 2 diabetes...(more)
American Diabetes Association  
May 23, 2013 15:00 ET
 

 

BIOTRONIK annonce la finalisation du recrutement pour l'étude IMPACT
BERLIN--(Marketwired - May 23, 2013) - BIOTRONIK, un fabricant de premier plan de technologies médicales novatrices, a annoncé aujourd'hui que le recrutement pour la très attendue étude IMPACT...(more)
BIOTRONIK SE. Co. KG  
May 23, 2013 12:15 ET
 

 

Novo Nordisk A/S : Novo Nordisk reports 8% weight loss in phase 3a obesity trial with liraglutide 3 mg
BAGSVAERD, DENMARK--(Marketwired - May 23, 2013) - Company announcement No 39 2013: http://hugin.info/2013/R/1704259/563495.pdf This announcement is distributed by Thomson Reuters on behalf of...(more)
Novo Nordisk A/S  
May 23, 2013 11:59 ET
 

 

College of Pharmacy Partners With TNI BioTech to Develop New Drugs for Africa
WASHINGTON, DC--(Marketwired - May 23, 2013) - Howard University College of Pharmacy has signed a multi-year agreement with TNI BioTech, Inc. (OTCQB: TNIB), a Bethesda, Md., biotech firm that...(more)
TNI BioTech, Inc.  
May 23, 2013 09:56 ET
 

 

BrainStorm Announces CEO Interview With The Wall Street Analyst
NEW YORK, NY and PETACH TIKVAH, ISRAEL--(Marketwired - May 23, 2013) - BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative...(more)
BrainStorm Cell Therapeutics, Inc.  
May 23, 2013 09:52 ET